Medpace Holdings, Inc.MEDPNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank92
3Y CAGR+10.8%
5Y CAGR+3.6%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+10.8%/yr
vs +15.3%/yr prior
5Y CAGR
+3.6%/yr
Recent acceleration
Acceleration
-4.5pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.40 | +31.3% |
| 2024 | 4.88 | -2.3% |
| 2023 | 4.99 | +6.0% |
| 2022 | 4.71 | -31.0% |
| 2021 | 6.83 | +27.5% |
| 2020 | 5.36 | +52.9% |
| 2019 | 3.50 | +31.2% |
| 2018 | 2.67 | -17.8% |
| 2017 | 3.25 | +6.3% |
| 2016 | 3.05 | - |